Themes Management Co LLC Buys 1,456 Shares of Axon Enterprise, Inc $AXON

Themes Management Co LLC lifted its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 65.8% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,668 shares of the biotechnology company’s stock after acquiring an additional 1,456 shares during the quarter. Axon Enterprise comprises approximately 1.0% of Themes Management Co LLC’s holdings, making the stock its 18th largest position. Themes Management Co LLC’s holdings in Axon Enterprise were worth $1,558,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Baillie Gifford & Co. lifted its holdings in Axon Enterprise by 1,198.7% in the 4th quarter. Baillie Gifford & Co. now owns 1,642,578 shares of the biotechnology company’s stock worth $932,869,000 after purchasing an additional 1,516,099 shares during the last quarter. Edgewood Management LLC acquired a new position in Axon Enterprise during the fourth quarter valued at approximately $846,516,000. Wellington Management Group LLP raised its position in shares of Axon Enterprise by 326.9% in the fourth quarter. Wellington Management Group LLP now owns 1,539,738 shares of the biotechnology company’s stock valued at $874,463,000 after purchasing an additional 1,179,038 shares during the period. Norges Bank bought a new position in shares of Axon Enterprise in the fourth quarter valued at approximately $515,764,000. Finally, Sands Capital Management LLC lifted its stake in shares of Axon Enterprise by 11.6% in the fourth quarter. Sands Capital Management LLC now owns 1,609,436 shares of the biotechnology company’s stock worth $914,047,000 after buying an additional 167,095 shares during the last quarter. Institutional investors own 79.08% of the company’s stock.

Insider Transactions at Axon Enterprise

In other news, CEO Patrick W. Smith sold 20,000 shares of the company’s stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $500.00, for a total value of $10,000,000.00. Following the sale, the chief executive officer directly owned 3,060,997 shares in the company, valued at approximately $1,530,498,500. This represents a 0.65% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CRO Cameron Brooks sold 1,242 shares of the company’s stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $500.00, for a total value of $621,000.00. Following the completion of the sale, the executive owned 49,710 shares in the company, valued at approximately $24,855,000. This represents a 2.44% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 58,989 shares of company stock valued at $30,527,983. Corporate insiders own 4.20% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently issued reports on AXON. Needham & Company LLC upped their price objective on shares of Axon Enterprise from $600.00 to $750.00 and gave the stock a “buy” rating in a report on Monday, July 6th. The Goldman Sachs Group set a $535.00 target price on shares of Axon Enterprise in a report on Thursday, May 7th. TD Cowen reissued a “buy” rating on shares of Axon Enterprise in a research report on Wednesday. Citizens Jmp restated a “market outperform” rating and set a $700.00 price target on shares of Axon Enterprise in a report on Thursday, June 25th. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday. Fifteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $725.25.

Axon Enterprise Trading Up 2.1%

Shares of Axon Enterprise stock opened at $502.34 on Friday. The firm has a market capitalization of $40.49 billion, a PE ratio of 201.74, a price-to-earnings-growth ratio of 10.25 and a beta of 1.38. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.27 and a quick ratio of 1.93. The company’s fifty day moving average price is $483.26 and its two-hundred day moving average price is $479.59. Axon Enterprise, Inc has a 52-week low of $339.01 and a 52-week high of $885.91.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings data on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.60 by $0.01. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. The company had revenue of $807.35 million during the quarter, compared to analysts’ expectations of $778.90 million. During the same quarter in the prior year, the company posted $1.47 EPS. The business’s revenue was up 33.7% on a year-over-year basis. On average, analysts expect that Axon Enterprise, Inc will post 1.63 EPS for the current year.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.